Harnessing the power of urinary miRNA to detect cancer early
Detecting cancers in early stages when it is treatable
Craif has harnessed the power of miRNA in cancer pathways to detect cancer in early stages when it is still treatable. Our primary focus is pancreatic cancer, which today is often detected too late to save lives.
Multi-cancer Early Detection Urine Test available in JapanmiSignal test can detect 7 types of cancer (pancreatic, colorectal, lung, stomach, esophagus breast, ovarian) from a simple urine draw.* available in Japan
Craif selected for Medtech Innovator 2024 Cohort,the world’s largest medtech accelerator
Craif Scientific Advisor and Co-founder Yasui’s research findings on ovarian cancer were published in Nature Communications
The Number of Medical Institution Installing miSignal®️ Achieved 300
Craif Announced New Product in miSignal®️ Series, “Remote Cancer TestTM”